Cite
MLA Citation
Jeffrey I Weitz et al.. “Biomarkers to predict risk of venous thromboembolism in patients with rheumatoid arthritis receiving tofacitinib or tumour necrosis factor inhibitors.” RMD open, vol. 8, no. 2, 2022, p. . http://access.bl.uk/ark:/81055/vdc_100169182471.0x000006